Jade Biosciences Inc (JBIO)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$13.95
Day's range
$14.64

Jade Biosciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 7.09 M $99.55 M   2.77% 12.26%
FAIRMOUNT FUNDS MANAGEMENT LLC 05/15/2026 4.55 M $63.98 M   0.00% 7.88%
RA CAPITAL MANAGEMENT, L.P. 05/15/2026 3.67 M $51.58 M   0.00% 6.35%
BELLEVUE GROUP AG 05/15/2026 3.50 M $49.20 M   4.80% 6.06%
VR ADVISER, LLC 05/15/2026 3.22 M $45.25 M   0.00% 5.57%
JANUS HENDERSON GROUP PLC 05/18/2026 3.11 M $43.56 M   100.00% 5.38%
BLACKROCK, INC. 05/13/2026 2.31 M $32.51 M   -19.38% 4.01%
VANGUARD CAPITAL MANAGEMENT LLC 05/15/2026 1.80 M $25.24 M   100.00% 3.11%
BAKER BROS. ADVISORS LP 05/15/2026 1.64 M $23.06 M   0.00% 2.84%
05/19/2026 1.58 M $22.17 M   0.00% 2.73%
VERSANT VENTURE MANAGEMENT, LLC 05/05/2026 1.53 M $21.44 M   0.00% 2.64%
AVIDITY PARTNERS MANAGEMENT LP 05/28/2026 1.40 M $19.68 M   0.00% 2.42%
SAMSARA BIOCAPITAL, LLC 05/15/2026 968.80 K $13.61 M   0.00% 1.68%
GREAT POINT PARTNERS LLC 05/15/2026 964.46 K $13.55 M   19.62% 1.67%
MARSHALL WACE, LLP 05/15/2026 944.78 K $13.27 M   7.94% 1.64%
ABRDN PLC 04/29/2026 867.28 K $12.19 M   0.00% 1.50%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 822.52 K $11.56 M   -2.29% 1.42%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/14/2026 796.74 K $11.19 M   0.00% 1.38%
ACORN CAPITAL ADVISORS, LLC 05/15/2026 786.76 K $11.05 M   100.00% 1.36%
STATE STREET CORP 05/15/2026 655.69 K $9.21 M   1.99% 1.13%
AFFINITY ASSET ADVISORS, LLC 05/14/2026 639.96 K $8.99 M   -10.49% 1.11%
DRIEHAUS CAPITAL MANAGEMENT LLC 05/15/2026 635.50 K $8.93 M   -28.37% 1.10%
RTW INVESTMENTS, LP 05/15/2026 573.21 K $8.05 M   -60.45% 0.99%
IKARIAN CAPITAL, LLC 05/15/2026 512.35 K $7.20 M   70.78% 0.89%
OPALEYE MANAGEMENT INC. 05/15/2026 427.61 K $6.01 M   0.00% 0.74%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 402.49 K $5.65 M   100.00% 0.70%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 400.00 K $5.62 M   1.27% 0.69%
FORESITE CAPITAL MANAGEMENT VI LLC 05/15/2026 320.00 K $4.50 M   100.00% 0.55%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 264.32 K $3.71 M   -52.67% 0.46%
NORTHERN TRUST CORP 05/14/2026 241.91 K $3.40 M   -11.75% 0.42%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 219.50 K $3.08 M   100.00% 0.38%
05/08/2026 211.32 K $2.97 M   100.00% 0.37%
ORBIMED ADVISORS LLC 05/15/2026 185.01 K $2.60 M   -65.17% 0.32%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 05/11/2026 169.05 K $2.38 M   151.45% 0.29%
MILLENNIUM MANAGEMENT LLC 05/15/2026 160.05 K $2.25 M   154.82% 0.28%
STEMPOINT CAPITAL LP 05/18/2026 154.03 K $2.16 M   100.00% 0.27%
GOLDMAN SACHS GROUP INC 05/15/2026 153.04 K $2.15 M   134.22% 0.26%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2026 139.97 K $1.97 M   72.48% 0.24%
CITADEL ADVISORS LLC 05/15/2026 137.22 K $1.93 M   280.59% 0.24%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 135.04 K $1.90 M   94.02% 0.23%
WELLINGTON MANAGEMENT GROUP LLP 05/15/2026 129.17 K $1.81 M   25.87% 0.22%
RUSSELL INVESTMENTS GROUP, LTD. 05/08/2026 107.60 K $1.51 M   1,713.82% 0.19%
SOFINNOVA INVESTMENTS, INC. 05/15/2026 107.39 K $1.51 M   0.00% 0.19%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 91.65 K $1.29 M   -27.13% 0.16%
BANK OF NEW YORK MELLON CORP 05/05/2026 89.96 K $1.26 M   -21.71% 0.16%
XTX TOPCO LTD 05/15/2026 78.11 K $1.10 M   171.01% 0.14%
UBS GROUP AG 05/05/2026 65.02 K $913.56 K   -32.82% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/15/2026 57.60 K $809.28 K   -22.58% 0.10%
MORGAN STANLEY 05/15/2026 50.60 K $710.86 K   -36.57% 0.09%
NUVEEN, LLC 04/30/2026 46.24 K $649.62 K   -62.88% 0.08%

Jade Biosciences Inc institutional Ownership - FAQ's

During the previous two years, 136 institutional investors and hedge funds held shares of Jade Biosciences Inc. The most heavily invested institutionals were:

Pictet Asset Management Holding SA: 733,768

abrdn plc: 621,108

Walleye Capital LLC: 365,272

Russell Investments Group, Ltd.: 163,084

HealthInvest Partners AB: 88,556

Bank of New York Mellon Corp: 85,343

86.27% of Jade Biosciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 49.49 M shares in the last 24 months. This purchase volume represents approximately $714.08 M in transactions.